WallStSmart
CNMD

CONMED Corporation

NYSE: CNMD · HEALTHCARE · MEDICAL DEVICES

$35.96
-2.26% today

Updated 2026-04-29

Market cap
$1.18B
P/E ratio
25.39
P/S ratio
0.86x
EPS (TTM)
$1.51
Dividend yield
1.60%
52W range
$33 – $61
Volume
0.4M

CONMED Corporation (CNMD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+0.1%
Last 4 quarters
Revenue YoY growth
+7.9%
Most recent quarter
EPS YoY growth
+6.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.7%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-6.0%
2025-10-29
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-01-29$1.43+7.5%$38.69$38.39-0.8%
2025-10-29$1.08+2.9%$47.32$44.49-6.0%
2025-07-30$0.69-27.4%$50.29$51.15+1.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$1.33$1.43+7.5%$373.20M+7.9%
2025-09-30$1.05$1.08+2.9%$337.93M+6.7%
2025-06-30$0.95$0.69-27.4%$342.35M+3.1%
2025-03-31$0.81$0.95+17.3%$321.26M+2.9%
2024-12-31$1.20$1.34+11.7%$345.94M+5.8%
2024-09-30$1.00$1.05+5.0%$316.70M+4.0%
2024-06-30$0.91$0.98+7.7%$332.10M+4.5%
2024-03-31$0.74$0.79+6.8%$312.27M
2023-12-31$1.11$1.06-4.5%$327.05M
2023-09-30$0.83$0.90+8.4%$304.58M
2023-06-30$0.79$0.83+5.1%$317.65M
2023-03-31$0.60$0.66+10.0%

Frequently asked questions

Has CONMED Corporation beaten earnings estimates?
CONMED Corporation has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +0.1% over the last 4 quarters.
How does CNMD stock react to earnings?
CNMD stock has moved an average of -1.7% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is CONMED Corporation's revenue growth rate?
CONMED Corporation reported year-over-year revenue growth of +7.9% in its most recent quarter, with EPS growing +6.7% year-over-year.